BRIEF-Agenus commences phase 1 clinical trial of antibody to treat solid tumors By: Reuters: Company News April 27, 2016 at 09:23 AM EDT * Agenus Commences Phase 1 Clinical Trial Of Its CTLA 4 checkpoint antibody to treat solid tumors Read More >> Related Stocks: Agenus Inc